Balter Invenomic Fund Fundamentals
BIVRX Fund | USD 17.09 0.10 0.58% |
Balter Invenomic Fund fundamentals help investors to digest information that contributes to Balter Invenomic's financial success or failures. It also enables traders to predict the movement of Balter Mutual Fund. The fundamental analysis module provides a way to measure Balter Invenomic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Balter Invenomic mutual fund.
Balter |
Balter Invenomic Fund Mutual Fund Three Year Return Analysis
Balter Invenomic's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Balter Invenomic Three Year Return | 19.47 % |
Most of Balter Invenomic's fundamental indicators, such as Three Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Balter Invenomic Fund is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
Competition |
Based on the latest financial disclosure, Balter Invenomic Fund has a Three Year Return of 19.4718%. This is much higher than that of the Invenomic family and significantly higher than that of the Long-Short Equity category. The three year return for all United States funds is notably lower than that of the firm.
Balter Invenomic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Balter Invenomic's current stock value. Our valuation model uses many indicators to compare Balter Invenomic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Balter Invenomic competition to find correlations between indicators driving Balter Invenomic's intrinsic value. More Info.Balter Invenomic Fund is the top fund in annual yield among similar funds. It also is the top fund in year to date return among similar funds creating about 73.34 of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balter Invenomic's earnings, one of the primary drivers of an investment's value.Balter Three Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Balter Invenomic's direct or indirect competition against its Three Year Return to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics of similar companies.Balter Invenomic is currently under evaluation in three year return among similar funds.
Fund Asset Allocation for Balter Invenomic
The fund invests most of its assets under management in cash or cash equivalents, with the rest of investments concentrated in stocks.Asset allocation divides Balter Invenomic's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Balter Fundamentals
Total Asset | 124.43 M | ||||
Annual Yield | 0.02 % | ||||
Year To Date Return | 1.81 % | ||||
One Year Return | (11.28) % | ||||
Three Year Return | 19.47 % | ||||
Five Year Return | 23.17 % | ||||
Net Asset | 1.4 B | ||||
Cash Position Weight | 70.47 % | ||||
Equity Positions Weight | 29.55 % |
About Balter Invenomic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Balter Invenomic Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years and in initial public offerings of securities .
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |